Literature DB >> 18332170

Pharmacodynamic analysis and clinical trial of amoxicillin sprinkle administered once daily for 7 days compared to penicillin V potassium administered four times daily for 10 days in the treatment of tonsillopharyngitis due to Streptococcus pyogenes in children.

M E Pichichero1, J R Casey, S L Block, R Guttendorf, H Flanner, D Markowitz, S Clausen.   

Abstract

An a priori pharmacokinetic/pharmacodynamic (PK/PD) target of 40% daily time above the MIC (T >MIC; based on the MIC(90) of 0.06 microg/ml for Streptococcus pyogenes reported in the literature) was shown to be achievable in a phase 1 study of 23 children with a once-daily (QD) modified-release, multiparticulate formulation of amoxicillin (amoxicillin sprinkle). The daily T >MIC achieved with the QD amoxicillin sprinkle formulation was comparable to that achieved with a four-times-daily (QID) penicillin VK suspension. An investigator-blinded, randomized, parallel-group, multicenter study involving 579 children 6 months to 12 years old with acute streptococcal tonsillopharyngitis was then undertaken. Children were randomly assigned 1:1 to receive either the amoxicillin sprinkle (475 mg for ages 6 months to 4 years, 775 mg for ages 5 to 12 years) QD for 7 days or 10 mg/kg of body weight of penicillin VK QID for 10 days (up to the maximum dose of 250 mg QID). Unexpectedly, the rates of bacteriological eradication at the test of cure were 65.3% (132/202) for the amoxicillin sprinkle and 68.0% (132/194) for penicillin VK (95% confidence interval, -12.0% to 6.6%). Thus, neither antibiotic regimen met the minimum criterion of > or =85% eradication ordinarily required by the U.S. FDA for first-line treatment of tonsillopharyngitis due to S. pyogenes. The results of subgroup analyses across demographic characteristics and current infection characteristics and by age/weight categories were consistent with the primary-efficacy result. The clinical cure rates for amoxicillin sprinkle and penicillin VK were 86.1% (216/251) and 91.9% (204/222), respectively (95% confidence interval, -11.6% to -0.4%). The results of a post hoc PD analysis suggested that a requirement for 60% daily T >MIC(90) more accurately predicted the observed high failure rates for bacteriologic eradication with the amoxicillin sprinkle and penicillin VK suspension studied. Based on the association between longer treatment courses and maximal bacterial eradication rates reported in the literature, an alternative composite PK/PD target taking into consideration the duration of therapy, or total T >MIC, was considered and provides an alternative explanation for the observed failure rate of amoxicillin sprinkle.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18332170      PMCID: PMC2443932          DOI: 10.1128/AAC.00132-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  43 in total

1.  Effect of schedule of administration on the therapeutic efficacy of penicillin; importance of the aggregate time penicillin remains at effectively bactericidal levels.

Authors:  H EAGLE; R FLEISCHMAN; A D MUSSELMAN
Journal:  Am J Med       Date:  1950-09       Impact factor: 4.965

2.  Comparison of cefdinir and penicillin for the treatment of pediatric streptococcal pharyngitis.

Authors:  M A Nemeth; W M Gooch; J Hedrick; E Slosberg; C H Keyserling; K J Tack
Journal:  Clin Ther       Date:  1999-09       Impact factor: 3.393

Review 3.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

Review 4.  Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

Authors:  W A Craig
Journal:  Clin Infect Dis       Date:  1998-01       Impact factor: 9.079

5.  A study of 5-day cefdinir treatment for streptococcal pharyngitis in children. Cefdinir Pediatric Pharyngitis Study Group.

Authors:  K J Tack; J A Hedrick; E Rothstein; M A Nemeth; C Keyserling; M E Pichichero
Journal:  Arch Pediatr Adolesc Med       Date:  1997-01

6.  6-day amoxicillin versus 10-day penicillin V for group A beta-haemolytic streptococcal acute tonsillitis in adults: a French multicentre, open-label, randomized study. The French Study Group Clamorange.

Authors:  D Peyramond; H Portier; P Geslin; R Cohen
Journal:  Scand J Infect Dis       Date:  1996

7.  Six-day amoxicillin vs. ten-day penicillin V therapy for group A streptococcal tonsillopharyngitis.

Authors:  R Cohen; C Levy; C Doit; F De La Rocque; M Boucherat; F Fitoussi; J Langue; E Bingen
Journal:  Pediatr Infect Dis J       Date:  1996-08       Impact factor: 2.129

8.  Use of available dosage forms of cephalexin in clinical comparison with phenoxymethyl penicillin and benzathine penicillin in the treatment of streptococcal pharyngitis in children.

Authors:  J M Matsen; O Torstenson; S E Siegel; H Bacaner
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

9.  Once-daily therapy for streptococcal pharyngitis with amoxicillin.

Authors:  H M Feder; M A Gerber; M F Randolph; P S Stelmach; E L Kaplan
Journal:  Pediatrics       Date:  1999-01       Impact factor: 7.124

Review 10.  Diagnosis and treatment of pharyngitis in children.

Authors:  Michael A Gerber
Journal:  Pediatr Clin North Am       Date:  2005-06       Impact factor: 3.278

View more
  7 in total

Review 1.  Streptococcal pharyngitis in children: to treat or not to treat?

Authors:  Daan Van Brusselen; Erika Vlieghe; Petra Schelstraete; Frederic De Meulder; Christine Vandeputte; Kristien Garmyn; Wim Laffut; Patrick Van de Voorde
Journal:  Eur J Pediatr       Date:  2014-08-12       Impact factor: 3.183

2.  Dose Rationale for Amoxicillin in Neonatal Sepsis When Referral Is Not Possible.

Authors:  Salvatore D'Agate; Flora Tshinanu Musuamba; Oscar Della Pasqua
Journal:  Front Pharmacol       Date:  2020-09-25       Impact factor: 5.810

Review 3.  Update on the management of acute pharyngitis in children.

Authors:  Marta Regoli; Elena Chiappini; Francesca Bonsignori; Luisa Galli; Maurizio de Martino
Journal:  Ital J Pediatr       Date:  2011-01-31       Impact factor: 2.638

4.  Characterization of 22 Antituberculosis Drugs for Inhibitory Interaction Potential on Organic Anionic Transporter Polypeptide (OATP)-Mediated Uptake.

Authors:  M Masud Parvez; Jin Ah Jung; Ho Jung Shin; Dong Hyun Kim; Jae-Gook Shin
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

Review 5.  Different antibiotic treatments for group A streptococcal pharyngitis.

Authors:  Mieke L van Driel; An Im De Sutter; Hilde Habraken; Sarah Thorning; Thierry Christiaens
Journal:  Cochrane Database Syst Rev       Date:  2016-09-11

6.  Different antibiotic treatments for group A streptococcal pharyngitis.

Authors:  Mieke L van Driel; An Im De Sutter; Sarah Thorning; Thierry Christiaens
Journal:  Cochrane Database Syst Rev       Date:  2021-03-17

Review 7.  Phenoxymethylpenicillin Versus Amoxicillin for Infections in Ambulatory Care: A Systematic Review.

Authors:  Philip Lawrence Skarpeid; Sigurd Høye
Journal:  Antibiotics (Basel)       Date:  2018-09-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.